CORBUS PHARMACEUTICALS HOLDI (CRBP) Stock Analyst Earnings Estimates
NASDAQ:CRBP - Nasdaq - US21833P3010 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 36.14M 649.79% | 3.94M -89.10% | 880K -77.66% | -100.00% | 1.275M | 4.718M 270.04% | 4.31M -8.65% | 33.317M 673.02% | 114.85M 244.72% | 285.93M 148.96% | 426.95M 49.32% | 664.97M 55.75% | |||
| EBITDA YoY % growth | -76.36M -35.73% | -121.69M -59.36% | -54.99M 54.81% | N/A 38.03% | N/A -30.16% | N/A -9.14% | N/A | N/A | -89.658M | -93.228M -3.98% | -100.674M -7.99% | -88.842M 11.75% | 3.672M 104.13% | 110.16M 2,900.00% | |
| EBIT YoY % growth | -77.1M -35.86% | -122.81M -59.29% | -55.99M 54.41% | -39.39M 37.77% | -45.978M -29.16% | -52.154M -8.89% | -74.001M -51.02% | -84.891M -14.72% | -123.787M -45.82% | -158.292M -27.88% | -155.285M 1.90% | -15.961M 89.72% | 98.697M 718.37% | 303.94M 207.95% | |
| Operating Margin | -213.34% | -3,117.01% | -6,362.50% | N/A | N/A | N/A | -5,804.03% | -1,799.30% | -2,872.08% | -475.11% | -135.21% | -5.58% | 23.12% | 45.71% | |
| EPS YoY % growth | -1.13 -15.31% | -1.47 -30.09% | -7.64 -419.73% | -9.64 -36.26% | -11.22 2.50% | -4.30 63.94% | -6.22 -69.83% | -5.01 19.39% | -6.01 -19.93% | -6.20 -3.18% | -5.39 13.14% | 0.88 116.31% | 6.25 611.05% | 14.34 129.50% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.74 -51.70% | -1.65 -111.85% | -1.28 8.20% | -1.46 -1.58% | -1.60 8.29% | -1.76 -6.48% |
| Revenue Q2Q % growth | 1.275M | -100.00% | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -20.372M -31.39% | -19.872M -57.65% | -20.349M -2.90% | -23.766M -24.09% | -25.704M -26.18% | -27.846M -40.12% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.44 -60.00% | -1.54 | 0.10 | 6.63% |
| Q1 2025 Q2Q % growth | -1.39 -67.47% | -1.31 | -0.08 | -6.46% |
| Q4 2024 Q2Q % growth | -0.78 56.91% | -1.29 | 0.51 | 39.57% |
| Q3 2024 Q2Q % growth | -1.15 43.90% | -0.97 | -0.18 | -18.43% |
| Q2 2024 Q2Q % growth | -0.90 56.10% | -1.21 | 0.31 | 25.73% |
| Q1 2024 Q2Q % growth | -0.83 80.42% | -1.11 | 0.28 | 25.35% |
| Q4 2023 Q2Q % growth | -1.81 30.65% | -2.41 | 0.60 | 24.81% |
| Q3 2023 Q2Q % growth | -2.05 2.38% | -2.10 | 0.05 | 2.44% |
| Q2 2023 Q2Q % growth | -2.05 37.88% | -3.16 | 1.11 | 35.17% |
| Q1 2023 Q2Q % growth | -4.24 -76.67% | -4.17 | -0.07 | -1.63% |
| Q4 2022 Q2Q % growth | -2.61 -8.75% | -2.14 | -0.47 | -21.85% |
| Q3 2022 Q2Q % growth | -2.10 -250.00% | -1.68 | -0.42 | -24.78% |
| Q2 2022 Q2Q % growth | -3.30 26.67% | -1.84 | -1.46 | -79.74% |
| Q1 2022 Q2Q % growth | -2.40 -1,614.29% | -2.60 | 0.20 | 7.73% |
| Q4 2021 Q2Q % growth | -2.40 -2,300.00% | -3.44 | 1.04 | 30.28% |
| Q3 2021 Q2Q % growth | -0.60 -42.86% | -3.52 | 2.92 | 82.95% |
| Q2 2021 Q2Q % growth | -4.50 -765.38% | -3.61 | -0.89 | -24.63% |
| Q1 2021 Q2Q % growth | -0.14 67.44% | -0.15 | 0.01 | 8.50% |
| Q4 2020 Q2Q % growth | -0.10 75.61% | -0.26 | 0.16 | 61.10% |
| Q3 2020 Q2Q % growth | -0.42 -31.25% | -0.43 | 0.01 | 1.96% |
| Q2 2020 Q2Q % growth | -0.52 -1,833.33% | -0.39 | -0.13 | -31.68% |
| Q1 2020 Q2Q % growth | -0.43 | -0.41 | -0.02 | -4.95% |
| Q4 2019 Q2Q % growth | -0.41 | -0.37 | -0.04 | -12.28% |
| Q3 2019 Q2Q % growth | -0.32 | -0.39 | 0.07 | 17.87% |
| Q2 2019 Q2Q % growth | 0.03 | -0.36 | 0.39 | 108.26% |
| Q1 2019 Q2Q % growth | -0.43 | -0.28 | -0.15 | -54.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | -100.00% | 102K | -102K | -100.00% |
| Q1 2022 Q2Q % growth | -100.00% | 153K | -153K | -100.00% |
| Q4 2021 Q2Q % growth | -100.00% | 354.45K | -354.45K | -100.00% |
| Q3 2021 Q2Q % growth | 100K -91.87% | 665.04K | -565.04K | -84.96% |
| Q2 2021 Q2Q % growth | 140K -51.72% | 892.5K | -752.5K | -84.31% |
| Q1 2021 Q2Q % growth | 650K -63.07% | 983.79K | -333.79K | -33.93% |
| Q4 2020 Q2Q % growth | 660K -74.32% | 1.52M | -860K | -56.58% |
| Q3 2020 Q2Q % growth | 1.23M -52.51% | 2.749M | -1.519M | -55.26% |
| Q2 2020 Q2Q % growth | 290K -99.00% | 3.052M | -2.762M | -90.50% |
| Q1 2020 Q2Q % growth | 1.76M -6.88% | 2.46M | -700K | -28.46% |
| Q4 2019 Q2Q % growth | 2.57M | 3.759M | -1.189M | -31.63% |
| Q3 2019 Q2Q % growth | 2.59M | 1.875M | 715K | 38.13% |
| Q2 2019 Q2Q % growth | 29.09M | 3.153M | 25.937M | 822.61% |
| Q1 2019 Q2Q % growth | 1.89M | 1.562M | 328K | 21.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0.23% | 0% | -17.62% |
| Revenue | N/A | N/A | 0% | -25% |